VEGF and CD31 association in pituitary adenomas

Endocrine Pathology

Volumn 21, Issue 3, 2010, Pages 154-160

  Cristina, Carolina ^a,b   Perez Millan, María Inés ^a   Luque, Guillermina ^a   Dulce, Raúl Ariel ^a   Sevlever, Gustavo ^c   Berner, Silvia Inés ^d   Becu Villalobos, Damasia ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b Universidad Nacional del Noroeste de la Provincia de Buenos Aires   (Argentina)

^c FLENI   (Argentina)

^d Hospital Oftalmologico Santa Lucia   (Argentina)

Author keywords

Angiogenesis; CD31; Pelioisis; Pituitary adenoma; Proliferation; VEGF

Indexed keywords

CD31 ANTIGEN; CYCLINE; KI 67 ANTIGEN; VASCULOTROPIN;

ADULT; AGE; ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CORRELATION ANALYSIS; DISEASE COURSE; EPITHELIUM CELL; FEMALE; GENDER; GROWTH HORMONE SECRETING ADENOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL; PROLACTINOMA; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

ADENOMA; ADULT; ANTIGENS, CD31; BLOTTING, WESTERN; FEMALE; HUMANS; MALE; PITUITARY NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956472773     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-010-9119-6     Document Type: Article

References (41)

1. J Folkman Y Shing 1992 Angiogenesis J Biol Chem 267 10931 4 1:CAS:528:DyaK38XksVSmu7s%3D 1375931
2. J Schechter 1972 Ultrastructural changes in the capillary bed of human pituitary tumors Am J Pathol 67 109 26 1:STN:280:DyaE383ms1ensw%3D%3D 5055626
3. M Jugenburg K Kovacs L Stefaneanu BW Scheithauer 1995 Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: a quantitative morphologic study Endocr Pathol 6 115 24 10.1007/BF02739874 12114647
4. HE Turner Z Nagy KC Gatter MM Esiri AL Harris JA Wass 2000 Angiogenesis in pituitary adenomas and the normal pituitary gland J Clin Endocrinol Metab 85 1159 62 10.1210/jc.85.3.1159 1:CAS:528:DC%2BD3cXisFOqsrg%3D 10720055 (Pubitemid 32269365)
5. K Takada S Yamada A Teramoto 2004 Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas Endocr Pathol 15 131 9 10.1385/EP:15:2:131 15299199 (Pubitemid 39179424)
6. CB Pizarro MC Oliveira JF Pereira-Lima CG Leaes CK Kramer T Schuch LM Barbosa-Coutinho NP Ferreira 2009 Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker Neuropathology 29 40 4 10.1111/j.1440-1789. 2008.00937.x 18673444
7. A Di Ieva F Grizzi P Gaetani U Goglia M Tschabitscher P Mortini R Baena 2008 Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue Neurosurg Rev 31 271 81 10.1007/s10143-008-0127-7 18327622
8. HE Turner AL Harris S Melmed JA Wass 2003 Angiogenesis in endocrine tumors Endocr Rev 24 600 32 10.1210/er.2002-0008 1:CAS:528:DC%2BD3sXptFGqtbw%3D 14570746 (Pubitemid 37330584)
9. S Vidal K Kovacs SM Cohen L Stefaneanu RV Lloyd BW Scheithauer 1999 Localization of vascular endothelial growth factor in non tumorous human pituitaries Endocr Pathol 10 109 22 10.1007/BF02739823
10. JH Mukdsi AL De Paul S Gutierrez FD Roth A Aoki AI Torres 2005 Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas J Mol Histol 36 447 54 10.1007/s10735-005-9012-7 1:CAS:528:DC%2BD28XltVOgtbw%3D 16733790 (Pubitemid 43829383)
11. RV Lloyd BW Scheithauer T Kuroki S Vidal K Kovacs L Stefaneanu 1999 Vascular Endothelial Growth Factor (VEGF) Expression in Human Pituitary Adenomas and Carcinomas Endocr Pathol 10 229 35 10.1007/BF02738884 1:CAS:528: DyaK1MXotVCit7w%3D 12114703
12. J Komorowski J Jankewicz H Stepien 2000 Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours Cytobios 101 151 9 1:CAS:528:DC%2BD3cXjtVGksLc%3D 10755214
13. A Gruszka J Kunert-Radek M Pawlikowski H Stepien 2005 Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with pituitary adenomas Pituitary 8 163 8 10.1007/s11102-005-5258-z 1:CAS:528:DC%2BD28XhvVSrt70%3D 16379029
14. P Lohrer J Gloddek U Hopfner M Losa E Uhl U Pagotto GK Stalla U Renner 2001 Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro Neuroendocrinology 74 95 105 10.1159/000054675 1:CAS:528:DC%2BD3MXlvF2gt74%3D 11474217 (Pubitemid 32727576)
15. R Nishikawa SY Cheng R Nagashima HJ Huang WK Cavenee M Matsutani 1998 Expression of vascular endothelial growth factor in human brain tumors Acta Neuropathol 96 453 62 10.1007/s004010050919 1:CAS:528:DyaK1cXmtFegtb8%3D 9829808 (Pubitemid 28474752)
16. CJ McCabe K Boelaert LA Tannahill AP Heaney AL Stratford JS Khaira S Hussain MC Sheppard JA Franklyn NJ Gittoes 2002 Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors J Clin Endocrinol Metab 87 4238 44 10.1210/jc.2002-020309 1:CAS:528:DC%2BD38XntFOls7c%3D 12213878
17. MS Mallea-Gil C Cristina MI Perez-Millan MC Ballarino AM Rodriguez Villafañe G Stalldecker D Becu-Villalobos 2009 Invasive giant prolactinoma with loss of therapeutic response to cabergoline: expression of angiogenic markers Endocr Pathol 20 35 50 10.1007/s12022-009-9057-3 1:CAS:528: DC%2BD1MXjsFyksrs%3D 19172414
18. C Cristina G Diaz-Torga A Baldi A Gongora M Rubinstein MJ Low D Becu-Villalobos 2005 Increased pituitary vascular endothelial growth factor-A in dopaminergic D2 receptor knockout female mice Endocrinology 146 2952 62 10.1210/en.2004-1445 1:CAS:528:DC%2BD2MXlslGhsLo%3D 15817666 (Pubitemid 41002802)
19. T Iuchi N Saeki K Osato A Yamaura 2000 Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas Acta Neurochir (Wien) 142 1345 51 10.1007/s007010070003 1:STN:280:DC%2BD3M7nvFyrug%3D%3D (Pubitemid 32204507)
20. M Niveiro FI Aranda G Peiro C Alenda A Pico 2005 Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas Hum Pathol 36 1090 5 10.1016/j.humpath.2005.07.015 1:CAS:528:DC%2BD2MXhtFWhsb3F 16226108 (Pubitemid 41443260)
21. P Viacava M Gasperi G Acerbi L Manetti E Cecconi AG Bonadio AG Naccarato F Acerbi G Parenti I Lupi M Genovesi E Martino 2003 Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas J Endocrinol Investig 26 23 8 1:CAS:528:DC%2BD3sXjtVKmtrg%3D
22. HE Turner Z Nagy KC Gatter MM Esiri AL Harris JA Wass 2000 Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome J Endocrinol 165 475 81 10.1677/joe.0.1650475 1:CAS:528: DC%2BD3cXjvFegtLs%3D 10810311
23. A Rivard JE Fabre M Silver D Chen T Murohara M Kearney M Magner T Asahara JM Isner 1999 Age-dependent impairment of angiogenesis Circulation 99 111 20 1:CAS:528:DyaK1MXnsFCrsg%3D%3D 9884387
24. J Itoh A Serizawa K Kawai Y Ishii A Teramoto RY Osamura 2003 Vascular networks and endothelial cells in the rat experimental pituitary glands and in the human pituitary adenomas Microsc Res Tech 60 231 5 10.1002/jemt.10261 12539177 (Pubitemid 36125711)
25. M Pawlikowski H Pisarek M Jaranowska 1997 Immunocytochemical investigations on the vascularization of pituitary adenomas Endocr Pathol 8 189 93 10.1007/BF02738785 12114722
26. S Vidal K Kovacs E Horvath BW Scheithauer T Kuroki RV Lloyd 2001 Microvessel density in pituitary adenomas and carcinomas Virchows Arch 438 595 602 10.1007/s004280000373 1:CAS:528:DC%2BD3MXkt1Kksbk%3D 11469692 (Pubitemid 32662379)
27. K Thapar K Kovacs BW Scheithauer L Stefaneanu E Horvath PJ Pernicone D Murray ER Laws Jr 1996 Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody Neurosurgery 38 99 106 10.1097/00006123-199601000-00024 1:STN:280:DyaK28zlsVShsw%3D%3D 8747957 (Pubitemid 26002389)
28. DW Hsu F Hakim BM Biller MS De la NT Zervas A Klibanski ET Hedley-Whyte 1993 Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence J Neurosurg 78 753 61 10.3171/jns.1993.78.5.0753 1:STN:280:DyaK3s3isV2ksQ%3D%3D 8096873
29. S Vidal E Horvath K Kovacs RV Lloyd BW Scheithauer 2003 Microvascular structural entropy: a novel approach to assess angiogenesis in pituitary tumors Endocr Pathol 14 239 47 10.1007/s12022-003-0016-0 14586069
30. HE Turner Z Nagy KC Gatter MM Esiri JA Wass AL Harris 2000 Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour Br J Cancer 82 1441 5 1:CAS:528:DC%2BD3cXivFGisbw%3D 10780524
31. JE Nor J Christensen DJ Mooney PJ Polverini 1999 Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression Am J Pathol 154 375 84 1:CAS:528:DyaK1MXjtVCqsbk%3D 10027396
32. K Arita K Kurisu A Tominaga K Sugiyama K Eguchi S Hama H Yoshioka F Yamasaki Y Kanou 2004 Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma Hiroshima J Med Sci 53 23 7 1:CAS:528:DC%2BD2cXotVGqu7c%3D 15453394
33. R Folberg MJ Hendrix AJ Maniotis 2000 Vasculogenic mimicry and tumor angiogenesis Am J Pathol 156 361 81 1:STN:280:DC%2BD3c7jt1yjtw%3D%3D 10666364
34. F Joseph N Younis G Haydon DH Adams S Wynne MB Gillet YM Maurice ME Lipton D Berstock IR Jones 2004 Peliosis of the spleen with massive recurrent haemorrhagic ascites, despite splenectomy, and associated with elevated levels of vascular endothelial growth factor Eur J Gastroenterol Hepatol 16 1401 6 10.1097/00042737-200412000-00027 15618852 (Pubitemid 39627544)
35. YN Park YB Kim KM Yang C Park 2000 Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis Arch Pathol Lab Med 124 1061 5 1:CAS:528: DC%2BD3cXlsFWjurc%3D 10888784
36. AK Wong M Alfert DH Castrillon Q Shen J Holash GD Yancopoulos L Chin 2001 Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome Proc Natl Acad Sci USA 98 7481 6 10.1073/pnas.121192298 1:CAS:528:DC%2BD3MXkslWlsrs%3D 11404464 (Pubitemid 32567974)
37. S Mohammed LV Syro BW Scheithauer A Abad H Uribe F Rotondo E Horvath M Cusimano K Kovacs 2009 Pituitary adenoma with peliosis: a report of two cases Endocr Pathol 20 41 5 10.1007/s12022-008-9056-9 19089655
38. CI Coire E Horvath K Kovacs HS Smyth S Ezzat 1997 Cushing's syndrome from an ectopic pituitary adenoma with peliosis: a histological, immunohistochemical, and ultrastructural study and review of the literature Endocr Pathol 8 65 74 10.1007/BF02739709 12114673
39. C Cristina I García-Tornadú G Diaz-Torga M Rubinstein MJ Low D Becu-Villalobos 2006 The dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma Front Horm Res 35 50 63 10.1159/000094308 1:CAS:528:DC%2BD28XhtFamsrfP 16809922 (Pubitemid 44024241)
40. F Kuchenbauer M Theodoropoulou U Hopfner J Stalla U Renner JC Tonn MJ Low E Arzt GK Stalla M Paez-Pereda 2003 Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development Mol Cell Endocrinol 207 13 20 10.1016/S0303-7207(03)00237-5 1:CAS:528:DC%2BD3sXntVyns7w%3D 12972179 (Pubitemid 37102949)
41. RV Lloyd S Vidal E Horvath K Kovacs B Scheithauer 2003 Angiogenesis in normal and neoplastic pituitary tissues Microsc Res Tech 60 244 50 10.1002/jemt.10263 1:CAS:528:DC%2BD3sXhsVGnt70%3D 12539179 (Pubitemid 36125713)